Screener
Innospec IOSP Impairment Charges
Impairment Charges at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Innospec in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.
The source filing: Innospec’s 10-Q, filed November 5, 2025.
- Filed
- Nov 5, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-266077
| (in millions, except share and per share data) | Three Months Ended September 30, 2025 | Three Months Ended September 30, 2024 | Nine Months Ended September 30, 2025 | Nine Months Ended September 30, 2024 |
|---|---|---|---|---|
| Research and development | (13.7) | (13.6) | (40.0) | (41.6) |
| Adjustment to fair value of contingent consideration | 17.7 | (0.7) | 16.2 | (2.1) |
| Restructuring charge | (0.9) | — | (0.9) | — |
| Impairment of property, plant and equipment | (22.9) | — | (22.9) | — |
| Impairment of intangible assets | (19.1) | — | (19.1) | — |
| Profit on disposal of property, plant and equipment | — | 0.1 | 0.2 | 0.2 |
| Total operating expenses | (110.8) | (78.5) | (282.3) | (269.9) |
| Operating income | 5.9 | 45.6 | 82.7 | 136.8 |
Item 1 Condensed Consolidated Financial Statements
FAQ
- What is Innospec's impairment charges?
- Innospec (IOSP) reported impairment charges of $22.9M in Q3 2025.
- What does impairment charges mean?
- Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.
Ask your AI about Innospec's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude